News
FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant access barriers for patients.
Web giant and partner CTC Global assert advanced conductors can double heavy-duty power line capacity in months versus a ...
1hon MSNOpinion
The federal government recently unveiled its One Canadian Economy Act, one of the first major pieces of legislation tabled by ...
13h
Discover Magazine on MSNFDA Approves Breakthrough HIV Drug, but It Could Be Hard to AccessLearn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.
Toyota GR Cup season reaches its halfway mark this weekend, as championship leader Nabil Abdool heads into Round 4 of The ...
Nurses who contracted long Covid remain trapped in a post-pandemic freeze frame, battling extreme fatigue, brain fog, ...
Southern Company's 60-year bond offers a 6.3% yield, nearly double its stock dividend, ideal for income investors seeking ...
22h
ZME Science on MSNScientists Detect Light Traversing the Entire Human Head—Opening a Window to the Brain’s Deepest RegionsTo test the limits, the researchers started by firing a powerful, ultrafast laser into the side of a volunteer’s head. The ...
The Focus on Sickle Cell Foundation (FoSCel) held a National Forum on Thursday, June 19, at the Jophus Anamuah-Mensah Conference Centre, University of Education, Winneba (UEW), drawing together ...
The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...
16h
Queerty on MSNFDA approves world’s first twice-yearly PrEP injectionThe FDA has approved a new, twice-yearly PrEP injection from pharmaceutical giant Gilead. The drug is lenacapavir. The ...
PAACA has called for urgent amendments to Nigeria's Electoral Act to empower INEC to regulate the cost of nomination forms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results